Aditya V. Goel

Adi joined Ampersand in 2025. Most recently, he was an Investment Analyst at Bracebridge Capital, where he invested across the capital structure in life sciences companies. Prior to that, Adi was a Senior Analyst at ClearView Healthcare Partners, consulting on biopharma strategy. Adi holds a B.A. in Molecular and Cell Biology from the University of California, Berkeley and an M.B.A. in Healthcare Management and Finance from Wharton.